Lite Strategy, Inc. Number of Reportable Segments
Lite Strategy, Inc. (LITS) reported Number of Reportable Segments of 2 Segment for the 12-month period ending 2014-06-30, per its 10-K filed 2014-09-09.
Discontinued › Notes
us-gaap:NumberOfReportableSegments · last filed 2014-09-09
- Lite Strategy, Inc. number of reportable segments for the quarter ending 2012-09-30 was 2.00 Segment.
- Lite Strategy, Inc. number of reportable segments for fiscal 2014 was 2.00 Segment, a 0.00% change from fiscal 2013.
- Lite Strategy, Inc. number of reportable segments for fiscal 2013 was 2.00 Segment, a 0.00% change from fiscal 2012.
- Lite Strategy, Inc. number of reportable segments for fiscal 2012 was 2.00 Segment.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2014-06-30 | 2.00 Segment 10-K · filed 2014-09-09 | |||
| 2013-06-30 | 2.00 Segment 10-K · filed 2013-09-18 | |||
| 2013-03-31 | 2.00 Segment 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | 2.00 Segment 10-Q · filed 2013-02-12 | |||
| 2012-09-30 | 2.00 Segment 10-Q · filed 2012-11-13 | |||
| 2012-06-30 | 2.00 Segment 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |